Phost'in Therapeutics
Research - Montpellier, Occitanie, France
Phost'in Therapeutics Employees
Phost'in Therapeutics Senior Management
Phost'in Therapeutics Details
Phost'in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost'in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors.
Website:
http://www.phostin.com
Employees:
14
HQ:
+33467163504
Location:
Montpellier, Occitanie, France
Revenue:
Phost'in Therapeutics Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly